Science
GENERIUM combines a world-class research center and a center for preclinical and clinical research that meets international GLP and GCP standards.
The idea of creating your own research center is to combine the efforts of leading Russian scientists, as well as to attract to Russia advanced knowledge and skills of modern science in the field of creation and development of innovative biotechnological drugs.
The company is capable to handle the full cycle of development of any medication from molecule design to commercial production. Scientific research on individual drugs is conducted jointly with biotechnology companies and scientific institutes from around the world.
The company's development strategy is to move from the development of generics to innovative developments. The project portfolio is formed of both original medications and biosimilars.
PipelineThe mission of the GENERIUM research units is to develop biotechnological medicines, cell technologies, gene therapy and chemical synthesis preparations to the stage of industrial application. The company's equipment and employee competencies make it possible to obtain almost any recombinant protein, monoclonal antibody and cellular product suitable for industrial production and preclinical and clinical studies.